1 / 4

Pipeline Drugs support Global Alzheimer’s Disease Therapeutics & Diagnostics Mar

The global Alzheimeru2019s disease therapeutics and diagnostics market is growing at a CAGR of 6.61% , and is expected to reach $12489.31 million by 2030. Read More.<br>

riannarodrigues
Download Presentation

Pipeline Drugs support Global Alzheimer’s Disease Therapeutics & Diagnostics Mar

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pipeline Drugs support Global Alzheimer’s Disease Therapeutics & Diagnostics Market Growth Inkwood Research estimates the Global Alzheimer’s Disease Therapeutics & Diagnostics Market to grow with a 6.61% CAGR during the forecasting years between 2022 and 2030, generating a revenue of $12489.31 million by 2030. Browse 61 market Data Tables and 52 Figures spread over 271 Pages, along with an in-depth analysis of the Global Alzheimer’s Disease Therapeutics & Diagnostics Market by Therapeutics & Diagnostics & Geography. This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by assessing major geographies and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis with input from industry professionals across the value chain. Global Alzheimer’s Disease Therapeutics & Diagnostics Market Scenario According to the Alzheimer’s Association, it is estimated that the prevalence of Alzheimer’s disease (AD) can be decreased by 50% if the onset of the disease can be delayed by five years. Therefore, many pipeline drugs are developed for cognitive enhancement or control of neuropsychiatric symptoms and working through neurotransmitter mechanisms. However, several pipeline molecules have been aiming at disease-modifying therapies, which prevent, delay, or slow the progression and only target underlying pathophysiologic mechanisms of Alzheimer’s disease (AD). These developments in the pipeline drugs positively impact the global market.

  2. Furthermore, rising R&D spending, the prevalence of chronic diseases like dementia, the increasing elderly population, and numerous cases of Alzheimer’s and neurodegenerative disorders are affecting the market’s growth rate. Huge investments in biomarkers and the increasing number of channels for drug development also propel the global Alzheimer’s disease therapeutics and diagnostics market growth. Moreover, innovative diagnostics and early diagnosis increase life expectancy in the general population and produce lucrative opportunities for the market. The Global Alzheimer’s Disease Therapeutics & Diagnostics Market report provides data tables and includes charts and graphs for visual analysis. Request Free Sample Report for the Global Alzheimer’s Disease Therapeutics & Diagnostics Market by Therapeutics & Diagnostics & Geography: https://inkwoodresearch.com/reports/alzheimers- disease-therapeutics-and-diagnostics-market/#request-free-sample Market Segmentation Market by Therapeutics & Diagnostics: Therapeutics oDrugs   Pipeline Drugs Marketed Drugs oGeneric & Branded  oGeneric Disease Stage    Branded Late-Stage: Severe AD Early/Middle Stage: Mild to Moderate AD Prodromal Stage Diagnostics oElectroencephalography oComputed Tomography oMagnetic Resonance Imaging oPositron Emission Tomography oLumbar Puncture Test oBlood Test oOther Diagnostics Report Highlights - The report provides a detailed analysis of the current and future market trends to identify the investment opportunities - Market forecasts till 2030, using estimated market values as the base numbers - Key market trends across the business segments, regions, and countries - Key developments and strategies observed in the market - Market dynamics such as drivers, restraints, opportunities, and other trends - In-depth company profiles of key players and upcoming prominent players

  3. - Growth prospects among the emerging nations through 2030 Companies Profiled SIEMENS HEALTHINEERS AG AMARANTUS BIOSCIENCE HOLDINGS INC EISAI CO LTD BIOGEN INC JOHNSON & JOHNSON COGNOPTIX INC NOVARTIS AG GE HEALTHCARE MERCK & CO INC PFIZER INC ELI LILLY & COMPANY LUPIN LIMITED TEVA PHARMACEUTICAL INDUSTRIES LIMITED F HOFFMANN-LA ROCHE ALLERGAN PLC (ACQUIRED BY ABBVIE) BAXTER INTERNATIONAL INC ZYDUS CADILA SUN PHARMACEUTICALS INDUSTRIES LTD Related Reports GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET - The global molecular point of care diagnostics market is expected to surge with a 14.90% CAGR between the estimated years 2019 and 2028. GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET - The global allergy diagnostic and treatment market is estimated to propel a CAGR of 5.50% between 2018 and 2026. GLOBAL COMPANION DIAGNOSTICS MARKET - The global companion diagnostics market is set to project a CAGR of 18.45% during the forecast years, 2018-2026. GLOBAL NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET - The global neurovascular devices / interventional neurology market is projected to record a CAGR of 5.08% between 2021 and 2028. Contact Us: Inkwood Research 169, Harrison Avenue Boston, MA 02111 Tel: 1-(857)293-0150

  4. Email: sales@inkwoodresearch.com Website: www.inkwoodresearch.com

More Related